Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: NWZ - podjęte uchwały: połączenie z Bulgarian Rose-Sevtopolis AD, emisja akcji połączeniowych, zmiany w statucie (2015-01-09)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 5:MINUTES OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF SOPHARMA AD – SOFIA, 9 JANUARY 2015

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. EGM 09.01.2015.zip MINUTES OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF SOPHARMA AD – SOFIA, 9 JANUARY 2015

POLISH FINANCIAL SUPERVISION AUTHORITY









UNI - EN REPORT No 5 / 2014





Date of issue: 2015-01-09
Short name of the issuer
SOPHARMA AD
Subject
MINUTES OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF SOPHARMA AD – SOFIA, 9 JANUARY 2015
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
We would hereby like to notify tha the Extraordinary General Meeting of Shareholders of Sopharma AD held on January 9, 2015 in Sofia took a decision for trnasformation of Sopharma AD throught the merger of Bulgarian Rose – Sevtopolis AD based in the city of Kazanlak, UIC 123007916. As a result the whole property of Bulgarian Rose – Sevtopolis AD will be transferred to Sopharma AD with the full rights.
The merger procedure will start according to the Contract for transofrmation through merger of Bulgarian Rose – Sevtopolis AD in Sopharma AD signed on June 19, 2014 and its Additional Agreements 1, 2 and 3.
All related applications are available on the internet page of Sopharma AD www.sopharma.bg and must be filed at the company address on 16, Iliensko Shose Str. in Sofia.
Annexes
File Description
EGM 09.01.2015.zip
EGM 09.01.2015.zip
MINUTES OF THE EXTRAORDINARY GENERAL
MEETING OF SHAREHOLDERS OF
SOPHARMA AD – SOFIA, 9 JANUARY 2015

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2015-01-09 Ognian Donev Executive director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 6.25 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama